Overview
Sari Jacoby is a Hematologist and an Oncologist in Newark, New Jersey. Dr. Jacoby is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Sickle Cell Disease, Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL), Hodgkin Lymphoma, Relapsed Refractory Multiple Myeloma (RRMM), and Bone Marrow Aspiration.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
201 Lyons Ave, D2, Newark, NJ 07112
Trustees Of Columbia University In The City Of New York
Eun-ju Lee is a Hematologist in New York, New York. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Immune Thrombocytopenic Purpura (ITP), Thrombocytopenia, Adult Immune Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, and Splenectomy.
Trustees Of Columbia University In The City Of New York
David Diuguid is a Hematologist in New York, New York. Dr. Diuguid has been practicing medicine for over 46 years and is rated as a Distinguished provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Sickle Cell Disease, Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, and Hemangioma Thrombocytopenia Syndrome.
New York University
Rajeev Balmiki is an Oncologist and a Hematologist in New York, New York. Dr. Balmiki is rated as an Advanced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Immune Thrombocytopenic Purpura (ITP), Adult Immune Thrombocytopenia, Hemangioma Thrombocytopenia Syndrome, Thrombocytopenia, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Hodgkin LymphomaDr. Jacoby isDistinguished. Learn about Hodgkin Lymphoma.
- Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)
- Sickle Cell DiseaseDr. Jacoby isDistinguished. Learn about Sickle Cell Disease.
- Advanced
- Classical Hodgkin LymphomaDr. Jacoby isAdvanced. Learn about Classical Hodgkin Lymphoma.
- Colorectal CancerDr. Jacoby isAdvanced. Learn about Colorectal Cancer.
- Familial Colorectal CancerDr. Jacoby isAdvanced. Learn about Familial Colorectal Cancer.
- Hemoglobin C DiseaseDr. Jacoby isAdvanced. Learn about Hemoglobin C Disease.
- Hemoglobin E DiseaseDr. Jacoby isAdvanced. Learn about Hemoglobin E Disease.
- Hemoglobin SC DiseaseDr. Jacoby isAdvanced. Learn about Hemoglobin SC Disease.
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Jacoby isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Immune ThrombocytopeniaDr. Jacoby isExperienced. Learn about Adult Immune Thrombocytopenia.
- AgranulocytosisDr. Jacoby isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Jacoby isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.